Honda Canada reports June sales results (CNW Group via Yahoo! Finance)
Honda Canada Inc. reported combined June sales of 16,518 units by its Honda and Acura divisions, a 2% decrease over last June. The Honda Automobile Division reported June sales of 14,918 units, down 1%.
General Motors Canada June sales down 23.8 per cent: trucks slide 35 per cent (Canadian Business)
TORONTO - General Motors of Canada has reported a 23.8 per cent skid in June sales as truck sales plummeted more than 35 per cent compared with a year ago.
Toyota Canada bucks trend (The Globe and Mail)
Auto maker sets a June record as overall Canadian sales slip 5.7 per cent; GM Canada plummets 23.8 per cent
Canadian auto sales fall in June, but Toyota rises (Reuters via Yahoo! News)
Canadian auto sales were lower in June with another sharp skid at General Motors of Canada as rising gas prices weighed on demand for SUVs and light trucks, according to company figures released on Wednesday.
General Motors Canada truck sales fall 35 per cent in June, dragging down industry (The Canadian Press via Yahoo! Canada News)
TORONTO - Canadian sales of cars and light trucks, which had been holding up remarkably well for the most part in the first five months of 2008, took a sharp turn for the worse last month as the high price of gasoline cut demand for pickups, SUVs and gas guzzlers.
General Motors Canada truck sales fall 35 per cent in June, dragging down industry (Canadian Business)
David Paddon, The Canadian Press July 2, 2008 - 6:03 p.m.
Sales of new autos sink (Toronto Star)
A collapse in truck sales at industry leader General Motors pulled down the auto market in Canada last month as well as expectations for the remainder of the year.
GM Canada Sales Down Nearly 24 Percent In June (Manufacturing.net)
Canadian vehicle market leader reported a 23.8 percent skid in June sales as truck sales plummeted more than 35 percent compared with a year ago.
Acura Pharmaceuticals, Inc. Receives $5.0 Million Milestone Payment (PrimeNewswire via Yahoo! Finance)
PALATINE, Ill., June 30, 2008 -- Acura Pharmaceuticals, Inc. today announced the receipt of a $5.0 million milestone payment from King Pharmaceuticals, Inc. for successfully achieving the primary end points in Acura's pivotal Phase III study, AP-ADF-105.